Elizabeth H Stover

14PUBLICATIONS
117CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 14, 2026
Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial.

|Mar 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.

Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir

|Jan 27, 2025
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer.

Veronica Rendo, Michael Schubert, Nicholas Khuu

|Apr 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.

Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee

|Dec 07, 2023
Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.

Kimia Sorouri, Filipa Lynce, Colleen M Feltmate

|Apr 20, 2022
Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer.

Min Liu, Nabihah Tayob, Livius Penter

Pageof 3

Frequent Collaborators

7 joint publications

Panagiotis A Konstantinopoulos

4 joint publications

Catherine J Wu

3 joint publications

Aviv Regev

3 joint publications

Orit Rozenblatt-Rosen